Trial Profile
Selective Estrogen Receptor Modulators (SERMs) - A Potential New Treatment for Women of Child-bearing Age With Psychotic Symptoms of Schizophrenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary)
- Indications Schizophrenia and disorders with psychotic features
- Focus Therapeutic Use
- 06 Jan 2020 Status changed from recruiting to completed.
- 12 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 12 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.